PD-1 Blockade with Nivolumab in Relapsed or Refractory Hodgkin's Lymphoma
Preclinical studies suggest that Reed-Sternberg cells exploit the programmed death 1 (PD-1) pathway to evade immune detection. In classic Hodgkin's lymphoma, alterations in chro...